WuXi Biologics: Net profit in the first quarter decreased by 81.27% year-on-year.

On the evening of April 25th, Watson Pharmaceuticals released its first quarter report for 2025, with a revenue of 462 million yuan, a year-on-year decrease of 22.93%; the net profit attributable to the parent company was 2.6462 million yuan, a year-on-year decrease of 81.27%. During the reporting period, the company's sales receipts for vaccine products and government subsidies decreased by 170 million yuan compared to the same period last year.